These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15663483)

  • 21. Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1.
    Witan H; Gorlovoy P; Kaya AM; Koziollek-Drechsler I; Neumann H; Behl C; Clement AM
    Neurobiol Dis; 2009 Nov; 36(2):331-42. PubMed ID: 19660548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
    Wang H; Yang B; Qiu L; Yang C; Kramer J; Su Q; Guo Y; Brown RH; Gao G; Xu Z
    Hum Mol Genet; 2014 Feb; 23(3):668-81. PubMed ID: 24108104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death.
    Zhang F; Zhu H
    Biochim Biophys Acta; 2006 Mar; 1760(3):404-14. PubMed ID: 16431026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.
    Towne C; Raoul C; Schneider BL; Aebischer P
    Mol Ther; 2008 Jun; 16(6):1018-25. PubMed ID: 18414477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial amyotrophic lateral sclerosis-linked mutant SOD1 aberrantly interacts with tubulin.
    Kabuta T; Kinugawa A; Tsuchiya Y; Kabuta C; Setsuie R; Tateno M; Araki T; Wada K
    Biochem Biophys Res Commun; 2009 Sep; 387(1):121-6. PubMed ID: 19576169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.
    Wang H; Ghosh A; Baigude H; Yang CS; Qiu L; Xia X; Zhou H; Rana TM; Xu Z
    J Biol Chem; 2008 Jun; 283(23):15845-52. PubMed ID: 18367449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.
    Raoul C; Abbas-Terki T; Bensadoun JC; Guillot S; Haase G; Szulc J; Henderson CE; Aebischer P
    Nat Med; 2005 Apr; 11(4):423-8. PubMed ID: 15768028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.
    Lu L; Zheng L; Viera L; Suswam E; Li Y; Li X; Estévez AG; King PH
    J Neurosci; 2007 Jul; 27(30):7929-38. PubMed ID: 17652584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
    Zimmerman MC; Oberley LW; Flanagan SW
    J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis.
    Basso M; Pozzi S; Tortarolo M; Fiordaliso F; Bisighini C; Pasetto L; Spaltro G; Lidonnici D; Gensano F; Battaglia E; Bendotti C; Bonetto V
    J Biol Chem; 2013 May; 288(22):15699-711. PubMed ID: 23592792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
    Hayashi Y; Homma K; Ichijo H
    Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [RNAi and neurological disease].
    Yokota T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):973-5. PubMed ID: 16447777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant SOD1 instability: implications for toxicity in amyotrophic lateral sclerosis.
    Tiwari A; Hayward LJ
    Neurodegener Dis; 2005; 2(3-4):115-27. PubMed ID: 16909016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS.
    Zhai J; Lin H; Canete-Soler R; Schlaepfer WW
    Hum Mol Genet; 2005 Sep; 14(18):2629-40. PubMed ID: 16079151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
    Kabashi E; Valdmanis PN; Dion P; Rouleau GA
    Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALS-causing SOD1 mutations promote production of copper-deficient misfolded species.
    Ip P; Mulligan VK; Chakrabartty A
    J Mol Biol; 2011 Jun; 409(5):839-52. PubMed ID: 21549128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Implications of successful immunotherapy in ALS model mice].
    Urushitani M
    Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of functional small interfering RNAs targeting amyotrophic lateral sclerosis-associated mutant alleles.
    Geng CM; Ding HL
    Chin Med J (Engl); 2011 Jan; 124(1):106-10. PubMed ID: 21362317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
    Watanabe S; Nagano S; Duce J; Kiaei M; Li QX; Tucker SM; Tiwari A; Brown RH; Beal MF; Hayward LJ; Culotta VC; Yoshihara S; Sakoda S; Bush AI
    Free Radic Biol Med; 2007 May; 42(10):1534-42. PubMed ID: 17448900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.